A study on patients with chronic kidney disease (CKD) to assess treatment experience and patterns, effect of the treatment, patient outcomes and patient quality of life

Study identifier:D1843R00291

ClinicalTrials.gov identifier:NCT04034992

EudraCT identifier:N/A

CTIS identifier:N/A

Recruitment Complete

Official Title

An observational study collecting real-world data on patients with chronic kidney disease to assess: early treatment experience, treatment patterns, treatment effectiveness, patient outcomes and patient quality of life through prospective and retrospective data capture

Medical condition

Chronic Kidney Disease

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual enrollment

1052

Study type

Observational

Age

18 Years - 130 Years

Date

Study Start Date: 11 Sept 2019
Estimated Primary Completion Date: 30 Jun 2023
Estimated Study Completion Date: 30 Jun 2023

Study design

Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2023 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria